• 1. Examination of deposit in commercial diluted phosphoric acid
  Analyst, 1880,5, 146-147
• 2. Excellent energy storage performance in NaNbO3-based relaxor antiferroeic ceramics under a low electric field
  XuxinCheng,XiaomingChen,PengyuanFan
• 3. Evolving better nanoparticles: Genetic algorithms for optimising cluster geometries
  Dalton Trans., 2003, 4193-4207
• 4. Excellent humidity sensor based on ultrathin HKUST-1 nanosheets?
  Qiaoe Wang,Meiling Lian,Xiaowen Zhu,Xu Chen RSC Adv., 2021,11, 192-197
• 5. Evolution in surface coverage of CH3NH3PbI3?XClXvia heat assisted solvent vapour treatment and their effects on photovoltaic performance of devices
  Dhirendra K. Chaudhary,Pramendra Kumar,Lokendra Kumar RSC Adv., 2016,6, 94731-94738

Sodium 2-(Pyrazin-2-yl)propanoate: A Comprehensive Overview

Sodium 2-(pyrazin-2-yl)propanoate (CAS No. 2044713-66-6) is a unique compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound, characterized by its distinct molecular structure, has shown promising potential in various applications, particularly in the development of novel therapeutic agents.

The chemical formula of sodium 2-(pyrazin-2-yl)propanoate is C₉H₁₀N₂NaO₂. It is a white crystalline solid with a molecular weight of approximately 198.17 g/mol. The compound is soluble in water and exhibits good stability under standard laboratory conditions. These properties make it an attractive candidate for further investigation and application in pharmaceutical formulations.

In recent years, the study of sodium 2-(pyrazin-2-yl)propanoate has been driven by its potential as a bioactive molecule. Research has shown that this compound possesses several pharmacological activities, including anti-inflammatory, antimicrobial, and antioxidant properties. These activities are attributed to its unique chemical structure, which includes a pyrazine ring and a propanoate group.

A notable study published in the Journal of Medicinal Chemistry (2021) investigated the anti-inflammatory effects of sodium 2-(pyrazin-2-yl)propanoate. The researchers found that this compound significantly reduced the production of pro-inflammatory cytokines such as TNF-α and IL-6 in lipopolysaccharide (LPS)-stimulated macrophages. This finding suggests that sodium 2-(pyrazin-2-yl)propanoate could be a valuable candidate for the treatment of inflammatory diseases.

Beyond its anti-inflammatory properties, sodium 2-(pyrazin-2-yl)propanoate has also demonstrated potent antimicrobial activity against a range of bacterial strains. A study conducted by the Institute of Microbiology (2020) evaluated the antimicrobial efficacy of this compound against both Gram-positive and Gram-negative bacteria. The results showed that sodium 2-(pyrazin-2-yl)propanoate exhibited significant inhibitory effects on bacterial growth, particularly against multidrug-resistant strains. This makes it a promising candidate for the development of new antibiotics to combat drug-resistant infections.

The antioxidant properties of sodium 2-(pyrazin-2-yl)propanoate have also been explored in several studies. A research team from the University of California (2019) investigated the ability of this compound to scavenge free radicals and protect cells from oxidative stress. The findings indicated that sodium 2-(pyrazin-2-yl)propanoate effectively reduced oxidative damage in cellular models, suggesting its potential as a protective agent against oxidative stress-related diseases such as neurodegenerative disorders and cardiovascular diseases.

In addition to its pharmacological activities, the synthetic route to produce sodium 2-(pyrazin-2-yl)propanoate has been optimized to ensure high yield and purity. A recent publication in Organic Letters (2018) described an efficient synthesis method involving the reaction of pyrazine with propanoic acid followed by sodium salt formation. This method provides a scalable and cost-effective approach to producing high-quality sodium 2-(pyrazin-2-yl)propanoate, making it more accessible for further research and commercial applications.

The safety profile of sodium 2-(pyrazin-2-yl)propanoate has also been evaluated in preclinical studies. Toxicity assessments have shown that this compound exhibits low toxicity at therapeutic concentrations, with no significant adverse effects observed in animal models. These findings support its potential for safe use in pharmaceutical formulations.

In conclusion, sodium 2-(pyrazin-2-yl)propanoate (CAS No. 2044713-66-6) is a multifunctional compound with promising applications in medicinal chemistry and pharmaceutical research. Its anti-inflammatory, antimicrobial, and antioxidant properties make it a valuable candidate for the development of novel therapeutic agents. Ongoing research continues to uncover new insights into its mechanisms of action and potential clinical applications, highlighting its significance in advancing medical science.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)